SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?


To: Ploni who wrote (4936)3/10/1999 12:47:00 PM
From: Cacaito  Read Replies (2) | Respond to of 5736
 
Sprx and marketing partner Respironics get FDA approval of BiliCheck.

Check prnewswire or businesswire.

Many said that this was years away. Competition is here and now.

Respironics is a worldwide enterprise, their marketing power is proven.

CCSI has no partner.

No signifcant difference between devices.

USA market as per Sprx: $30 millions.

CCSI is in a tough position.